@article{204181,
  keywords = {Humans, Immunotherapy, Triple Negative Breast Neoplasms, Immunity, Cellular},
  author = {Yong Tang and Yibin Kang},
  title = {Microbial metabolite as icebreaker for immunotherapy},
  abstract = {<p>Immunotherapy has limited success in triple-negative breast cancer (TNBC). In this issue of Cell Metabolism, Wang et\&nbsp;al. found that microbial metabolite TMAO boosts CD8 T\&nbsp;cell-mediated antitumor immunity by inducing pyroptosis in tumor cells, enhancing the efficacy of immunotherapy in TNBC (Wang et\&nbsp;al., 2022).</p>
},
  year = {2022},
  journal = {Cell Metab},
  volume = {34},
  pages = {506-507},
  month = {04/2022},
  issn = {1932-7420},
  doi = {10.1016/j.cmet.2022.03.003},
  language = {eng},
}